Results 211 to 220 of about 233,415 (250)
Some of the next articles are maybe not open access.

PROSTATE-SPECIFIC ANTIGEN DENSITY

Urologic Clinics of North America, 1997
Nearly 20 years have passed since PSA was definitively identified. Throughout this period, its clinical application as a tumor marker has expanded significantly. Today, besides monitoring prostate cancer therapy, PSA is being used extensively in mass screening programs for early detection of adenocarcinoma of the prostate and has become the most ...
M C, Beduschi, J E, Oesterling
openaire   +2 more sources

Prostate-specific membrane antigen

The Prostate, 1997
In an effort to discover new prostate-specific antigens (PSAs) to enhance our understanding of the functions and behavior of the prostate and the complex processes involved in prostate tumor progression, the structure and function of the PSM antigen has been elucidated.The PSM antigen was recognized using the 7E11-C5.3 monoclonal antibody, generated ...
W R, Fair, R S, Israeli, W D, Heston
openaire   +2 more sources

Prostate-Specific Antigen

New England Journal of Medicine, 1987
After half a century of clinical application, the usefulness of prostatic acid phosphatase (PAP) as a marker for carcinoma of the prostate is being challenged. Historically the first of the "serum markers" for the presence of a human cancer,1 acid phosphatase is still measured in clinical laboratories all over the world.
openaire   +2 more sources

Prostate Specific Antigen

Deutsche medizinische Wochenschrift (1946), 1995
Prostate specific antigen (PSA) is a 34 000 Da molecular weight glycoprotein found exclusively in the prostate, prostatic fluid and seminal plasma.
openaire   +3 more sources

Prostatic Specific Antigen

1994
PSA is a 34-kDa 240-amino-acid glycoprotein produced exclusively by prostatic epithelial cells. PSA is a serine protease, is a member of the kallikrein gene family, and has a high sequence homology with human glandular kallikrein. It has chymotrypsin-, trypsin-, and esterase-like activities.
openaire   +2 more sources

Prostate-Specific Antigen

Australian family physician, 2012
This article forms part of our 'Tests and results' series for 2011 which aims to provide information about common tests that general practitioners order regularly. It considers areas such as indications, what to tell the patient, what the test can and cannot tell you, and interpretation of results.
openaire   +3 more sources

Biology of Prostate-Specific Antigen

Journal of Clinical Oncology, 2003
Prostate-specific antigen (PSA) is an androgen-regulated serine protease produced by both prostate epithelial cells and prostate cancer (PCa) and is the most commonly used serum marker for cancer. It is a member of the tissue kallikrein family, some of the members of which are also prostate specific.
Steven P, Balk   +2 more
openaire   +2 more sources

Prostate Specific Antigen

Home Health Care Management & Practice, 2015
The discovery of the prostate specific antigen (PSA) was a landmark achievement of the 20th century according to the American Cancer Society. As a result of this discovery, the PSA screening test was developed. Over the past few years, the mounting controversy over the specificity of this test led to revisions of the screening guidelines by several ...
openaire   +1 more source

The prostate-specific antigen test

Expert Opinion on Medical Diagnostics, 2013
Before the 1980s, prostate cancer (PC) was considered a deadly disease. The mortality-incidence ratio showed that 1 out of each 2 - 3 PC patients died of this disease. On the other hand, autopsy studies have shown that latent PC is common in middle-aged men.
openaire   +3 more sources

Home - About - Disclaimer - Privacy